Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
First-time investors should be aware of common mistakes that can lead to losses. Here’s what not to do for a successful start.
28,109 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
The inaugural Fortune-style Crypto 40 lays out who truly moves the crypto economy in 2026, led by Uniswap in DeFi and...
A niche battery company moved sharply higher as growth signals and product milestones drew investor attention. This a...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...
Markets lean on Treasurys as the only credible anchor amid volatility. Analysts say the U.S. debt market remains the ...
ULTY’s weekly payouts look generous on the surface, yet a deeper dive shows a growing dependence on returning princip...
Qualcomm and Arm tumble as the mobile-chip complex sinks on a broader market pullback, underscoring renewed risk-off ...
As SpaceX gears up for a public listing, investors are watching how the company plans to squeeze more profits from it...
SpaceX going public could redefine the balance of big-name holdings in passive portfolios. This guide explains what b...
Three years have passed since a notable millionaire interview. This update reveals how one couple grew their net wort...